22 Republican prosecutors ask for mifepristone security protocols

EXCLUSIVE: More than 20 prosecutors Republican general require the Trump administration to reintegrate security protocols for abortion drugs, saying that it poses “serious risks for women”.

In a letter obtained by Fox News Digital, 22 attorneys general called the Secretary of Health and Social Services Robert F. Kennedy Jr. and the Director of Food and Medicines Martin Makary to bring guarantees for the pills that have been abandoned by Obama and Biden administrations.

“Recent complete studies on the effects of the real world of medication to chemical abortion report the Mimenterison Groupe de Avéner.

The EPPA report says that the pill has damage to women, which means that 1 in 10 patients is experiencing a “serious unwanted event”, including hemorrhage, emergency visits and extra-uterine pregnancy.

The chief of the FDA has “no plans” for changes in abortion pill policy, but continues the security examination

More than 20 republican attorney general prosecutors require the Trump administration to reintegrate safety protocols for abortion drug. (AP photo / Allen G. Race)

The letter, led by the Kansas Attorney General, Kris Kobach, Come after Kennedy Jr. Asked Makary to examine the latest data on mifepristone and its security.

“On the basis of this review, the FDA should consider restoring the security protocols which it identified as necessary as recently that 2011 in its publication of a risk assessment and mitigation strategy (REM) for mifepristone, but which has been deleted by Obama and Biden administrations,” the letter indicates, adding that the drug must be removed from the market if the backup cannot be implemented.

“Alternatively, in light of serious risks for women who are currently prescribing this medication without crucial guarantees, and in the event that the FDA is unable to reintegrate the 2011 security protocols for Miffepristone, the FDA should consider removing the market mifeprist until it ends its review and can decide an action course based on objective security critics and security critics and workforce, prosecutors.

Senator Josh Hawley, R-MO., Also sent a letter to Kennedy Jr. last month, exhorting him to take immediate measures to reintegrate the security guardrapristoneguards following the secretary’s commitment to carry out a drug safety exam.

Kennedy Jr. had asked Makary to examine the latest data on mifepristone and his security. (Images Andrew Harnik / Getty)

Makary had previously declared that he did not intend to modify policies surrounding mifepristone but that the FDA would act if the data suggested that there was a security problem.

Mifepristone, who is taken with another drug called Misoprostol to end an early pregnancy, was approved for the first time by the FDA in 2000 after “a complete and complete review” revealed that it was safe and effective, according to the agency’s website, which noted that periodic journals since its approval had not identified new safety concerns.

Last year, the Supreme Court rejected a dispute targeting the availability of drugs. The complainants had sought to restrict access to mifepristone across the country, including in the States led by Democrats where abortion remains legal. The court did not decide whether the FDA acted legally when it moved during the Obama and Biden administrations to facilitate the rules for using Miffepristone which had been established during the Clinton administration.

Drug abortions were more than half of all abortions in the American health care system in 2023, according to a study by the Guttmacher Institute.

Medical groups urge the FDA, Kennedy to re -examine wide approval of abortion drugs

The letter of 22 general prosecutors was led by the Kansas Attorney General, Kris Kobach. (AP photo / John Hanna)

Click here to obtain the Fox News app

“Currently, a woman can obtain a mifepristone abortion by participating in a single viewer’s visit with any approved health care provider (not necessarily a doctor), commanding drugs through a correspondence pharmacy and the self-administer,” wrote the lawyers. “And the prescriber is only required to report an adverse event if he realizes that the patient has died.”

“The FDA elimination of these crucial safety protocols in 2016 (and in 2023) that only five years before the FDA was considered necessary for whether the suppression was motivated by considerations other than patient safety … The current FDA of health and the well-being of all Americans is encouraged, as the fact of the Mifepristone exam.